Intl Antiviral Research Organization Allays Concerns Over Availability Of Remdesivir Drug

Links to Files

https://www.urdupoint.com/en/world/intl-antiviral-research-organization-allays-921675.html

Permanent Link

http://hdl.handle.net/11603/39628

Collections

UMBC Faculty Collection
UMBC Chemistry & Biochemistry Department

Author/Creator

Author/Creator ORCID

https://orcid.org/0000-0002-0154-3459

Date

2020-05-15

Type of Work

articles
Text

Department

Program

Citation of Original Publication

FH, Sumaira and Katherine Seley-Radtke. "Intl Antiviral Research Organization Allays Concerns Over Availability Of Remdesivir Drug". UrduPoint. May 15, 2020. https://www.urdupoint.com/en/world/intl-antiviral-research-organization-allays-921675.html

Rights

This item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.

Subjects

Antiviral
Remdesivir Drug
COVID-19

Abstract

Katherine Seley-Radtke, a prominent medicinal chemist and the president-elect of the International Society for Antiviral Research (ISAR), dispelled concerns over the possible shortages of Remdesivir, an experimental antiviral drug for treating COVID-19 patients, which many fear takes too long to produce